[Experimental study of antibacterial activity, therapeutic effectiveness and toxic properties of the combination of tobramycin and carbenicillin].
Tobramycin combination with carbenicillin was studied experimentally. Tobramycin is a new aminoglycoside antibiotic prepared at the Institute of New Antibiotics, the USSR Academy of Medical Sciences. It was shown that the combination had mainly synergistic action (67 per cent) on clinical strains of Pseudomonas aeruginosa which was confirmed in treatment of experimental sepsis caused by the organism. In acute experiments with albino mice there was observed summation of the general toxic action of the antibiotics used in the combination. The level and nature of the nephrotoxic action of the tobramycin combination with carbenicillin were shown in experiments with rats to be the same as those of the nephrotoxic action of tobramycin used alone. The presence of carbenicillin in the combination did not increase the inhibitory effect of tobramycin on excitement transmission in the neuromuscular synapses.
Vinogradova
I V
IV
Filippos'iants
S T
ST
Shevniuk
L A
LA
D000818:Animals; D002228:Carbenicillin / Q000008:administration & dosage* / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D066298:In Vitro Techniques; D051379:Mice; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D014031:Tobramycin / Q000008:administration & dosage* / Q000633:toxicity
D002228:Carbenicillin; D014031:Tobramycin
Eksperimental'noe izuchenie antibakterial'noĭ aktivnosti, terapevticheskoĭ éffektivnosti i toksicheskikh svoĭstv kombinatsii tobramitsina s karbenitsillinom.